The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Works matching IS 11727047 AND DT 2015 AND VI 29 AND IP 7
Results: 9
1
2
[(18)F]Florbetaben: a review in β-amyloid PET imaging in cognitive impairment.
- Published in:
- 2015
- By:
- Publication type:
- journal article
3
[F]Florbetaben: A Review in β-Amyloid PET Imaging in Cognitive Impairment.
- Published in:
- CNS Drugs, 2015, v. 29, n. 7, p. 605, doi. 10.1007/s40263-015-0258-7
- By:
- Publication type:
- Article
4
Propofol: A Review of its Role in Pediatric Anesthesia and Sedation.
- Published in:
- CNS Drugs, 2015, v. 29, n. 7, p. 543, doi. 10.1007/s40263-015-0259-6
- By:
- Publication type:
- Article
5
The Therapeutic Potential of α Nicotinic Acetylcholine Receptor (α nAChR) Agonists for the Treatment of the Cognitive Deficits Associated with Schizophrenia.
- Published in:
- CNS Drugs, 2015, v. 29, n. 7, p. 529, doi. 10.1007/s40263-015-0260-0
- By:
- Publication type:
- Article
6
Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis.
- Published in:
- CNS Drugs, 2015, v. 29, n. 7, p. 565, doi. 10.1007/s40263-015-0261-z
- By:
- Publication type:
- Article
7
Antipsychotic Drug Use and the Risk of Seizures: Follow-up Study with a Nested Case-Control Analysis.
- Published in:
- CNS Drugs, 2015, v. 29, n. 7, p. 591, doi. 10.1007/s40263-015-0262-y
- By:
- Publication type:
- Article
8
The Prevalence, Measurement, and Treatment of the Cognitive Dimension/Domain in Major Depressive Disorder.
- Published in:
- CNS Drugs, 2015, v. 29, n. 7, p. 577, doi. 10.1007/s40263-015-0263-x
- By:
- Publication type:
- Article
9
Prevention Studies in Alzheimer's Disease: Progress Towards the Development of New Therapeutics.
- Published in:
- CNS Drugs, 2015, v. 29, n. 7, p. 519, doi. 10.1007/s40263-015-0256-9
- By:
- Publication type:
- Article